NeuroStar - STIM Company Total Asset Base

This chart shows that the current market value of total assets for Neuronetics, Inc. (STIM) is 133.06. While promotion costs and competition from pharmacology constrain the trend, the growing equipment base triggers economies of scale through the sale of profitable session maps. The business generates revenue by supplying TMS neurotechnology systems designed for the non-invasive therapy of deep depressive states on a global scale.

Neuronetics, Inc. (STIM) innovations in neurostimulation require significant capital expenditures to scale the business. By analyzing total asset trends, reverse-engineered via ROA, an investor assesses resource efficiency relative to net income. This chart reflects the balance between the growth of the asset base and the risks of slow technology adoption. Stable asset expansion in the absence of debt confirms the fundamental resilience of Neuronetics, Inc. (STIM).